|
1
|
Smith MG, Hold GL, Tahara E and El-Omar
EM: Cellular and molecular aspects of gastric cancer. World J
Gastroenterol. 12:2979–2990. 2006.PubMed/NCBI
|
|
2
|
Lee JH, Kim KM, Cheong JH and Noh SH:
Current management and future strategies of gastric cancer. Yonsei
Med J. 53:248–257. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sakamoto J, Matsui T and Kodera Y:
Paclitaxel chemotherapy for the treatment of gastric cancer.
Gastric Cancer. 12:69–78. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cao MR, Li Q, Liu ZL, Liu HH, Wang W, Liao
XL, Pan YL and Jiang JW: Harmine induces apoptosis in HepG2 cells
via mitochondrial signaling pathway. Hepatobiliary Pancreat Dis
Int. 10:599–604. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Liao X, Che X, Zhao W, Zhang D, Bi T and
Wang G: The β -adrenoceptor antagonist, propranolol, induces human
gastric cancer cell apoptosis and cell cycle arrest via inhibiting
nuclear factor κB signaling. Oncol Rep. 24:1669–1676.
2010.PubMed/NCBI
|
|
6
|
Zhang H, Sun K, Ding J, Xu H, Zhu L, Zhang
K, Li X and Sun W: Harmine induces apoptosis and inhibits tumor
cell proliferation, migration and invasion through down-regulation
of cyclooxygenase-2 expression in gastric cancer. Phytomedicine.
21:348–355. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sun WH, Sun YL, Fang RN, Shao Y, Xu HC,
Xue QP, Ding GX and Cheng YL: Expression of cyclooxygenase-2 and
matrix metalloproteinase-9 in gastric carcinoma and its correlation
with angiogenesis. Jpn J Clin Oncol. 35:707–713. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Huang F, Lin C, Shi YH and Kuerban G:
MicroRNA-101 inhibits cell proliferation, invasion, and promotes
apoptosis by regulating cyclooxygenase-2 in Hela cervical carcinoma
cells. Asian Pac J Cancer Prev. 14:5915–5920. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chan MW, Wong CY, Cheng AS, Chan VY, Chan
KK, To KF, Chan FK, Sung JJ and Leung WK: Targeted inhibition of
COX-2 expression by RNA interference suppresses tumor growth and
potentiates chemosensitivity to cisplatin in human gastric cancer
cells. Oncol Rep. 18:1557–1562. 2007.PubMed/NCBI
|
|
10
|
Sun WH, Zhu F, Chen GS, Su H, Luo C, Zhao
QS, Zhang Y, Shao Y, Sun J, Zhou SM, et al: Blockade of
cholecystokinin-2 receptor and cyclooxygenase-2 synergistically
induces cell apoptosis, and inhibits the proliferation of human
gastric cancer cells in vitro. Cancer Lett. 263:302–311. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ram M, Sherer Y and Shoenfeld Y: Matrix
metalloproteinase-9 and autoimmune diseases. J Clin Immunol.
26:299–307. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Velinov N, Poptodorov G, Gabrovski N and
Gabrovski S: The role of matrixmetalloproteinases in the tumor
growth and metastasis. Khirurgiia (Sofiia). 1:44–49. 2010.(In
Bulgarian). PubMed/NCBI
|
|
13
|
He XP, Shao Y, Li XL, Xu W, Chen GS, Sun
HH, Xu HC, Xu X, Tang D, Zheng XF, et al: Downregulation of miR-101
in gastric cancer correlates with cyclooxygenase-2 overexpression
and tumor growth. FEBS J. 279:4201–4212. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu W, Yang Q, Liu B and Zhu Z: Serum
proteomics for gastric cancer. Clin Chim Acta. 431:179–184. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Neugut AI, Hayek M and Howe G:
Epidemiology of gastric cancer. Semin Oncol. 23:281–291.
1996.PubMed/NCBI
|
|
16
|
Tuan TF, Tsai ML, Yeh KC, Huang HC, Chung
CT, Huang CL, Han CH, Chen CP, Wang MH, Shen CC, et al: Intravenous
paclitaxel against metastasis of human gastric tumors of diffuse
type. Cancer Chemother Pharmacol. 66:773–783. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Papadaki C, Mavroudis D, Trypaki M,
Koutsopoulos A, Stathopoulos E, Hatzidaki D, Tsakalaki E,
Georgoulias V and Souglakos J: Tumoral expression of TXR1 and TSP1
predicts overall survival of patients with lung adenocarcinoma
treated with first-line docetaxel-gemcitabine regimen. Clin Cancer
Res. 15:3827–3833. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Williams CS, Smalley W and DuBois RN:
Aspirin use and potential mechanisms for colorectal cancer
prevention. J Clin Invest. 100:1325–1329. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
O'Mahony CA, Beauchamp RD, Albo D, Tsujii
M, Sheng HM, Shao J, Dubois RN and Berger DH: Cyclooxygenase-2
alters transforming growth factor-beta 1 response during intestinal
tumorigenesis. Surgery. 126:364–370. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu XH, Kirschenbaum A, Yao S, Stearns ME,
Holland JF, Claffey K and Levine AC: Upregulation of vascular
endothelial growth factor by cobalt chloride-simulated hypoxia is
mediated by persistent induction of cyclooxygenase-2 in a
metastatic human prostate cancer cell line. Clin Exp Metastasis.
17:687–694. 1999. View Article : Google Scholar : PubMed/NCBI
|
